For the quarter ending 2026-01-02, ARMK had -$198,802K decrease in cash & cash equivalents over the period. -$1,236,981K in free cash flow.
| Cash Flow | 2026-01-02 | 2025-10-03 | 2025-06-27 | 2025-03-28 |
|---|---|---|---|---|
| Net income from continuing operations | - | 326,870 | - | - |
| Net income | -37,424 | - | 71,952 | 61,973 |
| Depreciation and amortization | 125,954 | 124,260 | 121,822 | 117,059 |
| Asset write-downs | 6,058 | 8,946 | - | - |
| Reduction of contingent consideration liability | - | -11,127 | - | - |
| Loss (gain) on equity investments, net (see note 1) | - | -19,465 | - | - |
| Increase in contingent consideration liability (see note 11) | 0 | - | 0 | 0 |
| Deferred income taxes | 22,869 | 14,482 | -3,194 | -6,525 |
| Share-based compensation expense | 16,316 | 13,922 | 14,425 | 15,448 |
| Receivables | 250,180 | -133,351 | 56,092 | -8,064 |
| Inventories | -8,145 | 25,449 | -17,219 | 29,796 |
| Prepayments and other current assets | 16,509 | 12,937 | -14,555 | 37,027 |
| Accounts payable | -255,257 | 391,186 | -23,898 | 9,810 |
| Accrued expenses | -446,911 | 424,582 | -86,781 | 126,035 |
| Payments made to clients on contracts | 101,408 | 23,660 | 12,603 | 25,818 |
| Changes in other noncurrent liabilities | - | -15,577 | - | - |
| Changes in other assets | - | -63,807 | - | - |
| Other operating activities | 12,222 | -28,058 | 19,272 | 16,725 |
| Net cash provided by operating activities of continuing operations | - | 921,035 | - | - |
| Net cash used in operating activities | -1,114,825 | - | 76,677 | 255,948 |
| Purchases of property and equipment and other | 122,156 | 142,201 | 111,378 | 115,800 |
| Disposals of property and equipment | 2,123 | 18,342 | 1,150 | 1,102 |
| Purchases of marketable securities | - | 0 | 0 | 0 |
| Proceeds from marketable securities | - | 43,936 | 0 | 0 |
| Acquisition of certain businesses, net of cash acquired | 32,753 | 524 | 15,243 | 136,434 |
| Acquisition of certain equity investments | - | 25,877 | - | - |
| Proceeds from sale of equity investments | - | 0 | - | - |
| Other investing activities | 934 | 1,922 | 6,237 | 499 |
| Net cash (used in) provided by investing activities of continuing operations | - | -722,424 | - | - |
| Net cash used in investing activities | 229,619 | - | -131,708 | -251,631 |
| Proceeds from long-term borrowings | 233,294 | -253,768 | 118,833 | 1,922,411 |
| Payments of long-term borrowings | 25,471 | 70,945 | 438,813 | 1,401,951 |
| Net change in funding under the receivables facility | 625,000 | -570,000 | -16,000 | 61,000 |
| Payments of dividends | 31,537 | 27,599 | 27,539 | 27,823 |
| Distribution from vestis | - | 0 | - | - |
| Proceeds from issuance of common stock | 3,196 | 6,546 | 20,048 | 4,402 |
| Repurchase of common stock | 41,262 | 29,671 | 30,873 | 109,283 |
| Payments for contingent considerations | 27,072 | 33,604 | - | - |
| Other financing activities | -452 | 65,036 | -12,843 | -24,890 |
| Net cash (used in) provided by financing activities of continuing operations | - | -234,628 | - | - |
| Net cash provided by operating activities | - | 0 | - | - |
| Net cash used in investing activities | - | 0 | - | - |
| Net cash provided by financing activities | - | 0 | - | - |
| Net cash provided by discontinued operations | - | 0 | - | - |
| Net cash provided by financing activities | 699,017 | - | -387,187 | 423,866 |
| Effect of foreign exchange rates on cash and cash equivalents and restricted cash | 1,422 | -3,871 | 25,916 | 7,463 |
| Decrease in cash and cash equivalents and restricted cash | -198,802 | 149,440 | -416,302 | 435,646 |
| Cash and cash equivalents at beginning of period | 707,144 | 557,704 | 974,006 | 538,360 |
| Cash and cash equivalents at end of period | 508,342 | 707,144 | 557,704 | 974,006 |
Aramark (ARMK)
Aramark (ARMK)